Search for other papers by Clara Lundetoft Clausen in
Google Scholar
PubMed
Search for other papers by Trine Holm Johannsen in
Google Scholar
PubMed
Search for other papers by Niels Erik Skakkebæk in
Google Scholar
PubMed
Search for other papers by Hanne Frederiksen in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Anders Juul in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Thomas Benfield in
Google Scholar
PubMed
important inhibitory effects towards pro-inflammatory mediators such as interleukin 6 (IL-6) ( 10 ). Therefore, in appropriate responses to critical illness and hyperinflammation, glucocorticoid levels are upregulated, attaining levels up to six
Search for other papers by Martin Wiegand in
Google Scholar
PubMed
Search for other papers by David J Halsall in
Google Scholar
PubMed
Search for other papers by Sarah L Cowan in
Google Scholar
PubMed
Search for other papers by Kevin Taylor in
Google Scholar
PubMed
Search for other papers by Robert J B Goudie in
Google Scholar
PubMed
Search for other papers by Jacobus Preller in
Google Scholar
PubMed
Wellcome–MRC Institute of Metabolic Science, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Addenbrooke’s Hospital, Cambridge, UK
Search for other papers by Mark Gurnell in
Google Scholar
PubMed
supplementary materials given at the end of this article), although these patients had lower interleukin-6 (median 8.1 vs 11.9); were less likely to be admitted to ICU (11.2% vs 18.9%); and were more likely to have diabetes (32.8% vs 20.7%) or other endocrine